FDA Approves Treosulfan as Part of AML/MDS Conditioning Regimen

(MedPage Today) -- The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and older with acute myeloid leukemia (AML) or myelodysplastic syndrome...